Healthcare, Pharmaceutical & Medical Private Equity

As the UK’s leading healthcare private equity firm, LDC is an active investor in the sector. We have supported nearly 40 healthcare companies investing over £315m in the sector.

The UK healthcare and pharmaceuticals sector continues to thrive. Fundamental growth drivers, including an ageing population, increasing influence of technology and demand for home care have created significant opportunity.

We have supported a diverse range of businesses across the healthcare sector ranging from healthcare communications specialist Fishawack Health, where we enabled five acquisitions to further international growth, to optometrists and hearing care chain Duncan & Todd Group to manufacturer and provider of specialist healthcare equipment Prism Medical and specials manufacturer Quantum Pharma, which completed a £130m IPO, further to 145% revenue growth during our five-year partnership.

Our team has an enviable track record in backing the growth ambitions of management teams from across the sector – with particular experience in the dynamic pharmaceutical, medical communications and medical equipment industries.

Read our ‘Ask the CEO’ brochure where we asked CEO of Ashtons Hospital Pharmacy Services Yachna Tak on why she chose private equity investment for her business and how she has safeguarded employees and customers in the COVID-19 pandemic.